REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$7.03
-0.36 (-4.87%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
10d
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: REPL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: REPL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $7.03, which is considered oversold relative to its 30-day fair value range of $7.27 to $9.27.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $6.77, while resistance sits at $7.91. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.57 (+70.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $6.77, while resistance sits at $7.91. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.57 (+70.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$7.27 -
$9.27
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.1%
Protect Your Profits
Holding REPL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 70.1% below Wall St target ($12.57)
- CAUTION: Recommendation downgraded due to -8.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$7.27 -
$9.27
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.95
(13.6%)
Support & Resistance Levels
Support Level
$6.77
Resistance Level
$7.91
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.58
Wall Street Target
$12.57
(+70.1%)
Last updated: January 31, 2026 12:01 AM ET
Data refreshes hourly during market hours. Next update: 1:01 AM
Data refreshes hourly during market hours. Next update: 1:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Emily Luisa Hill
SELL
9154 shares
2025-08-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
